![【重磅录像】颜宁:“AI在结构生物学中的未达之地”](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
编者按
药时代一直在关注阿尔兹海默病及新药研发,近日发布的关于TB006的系列文章都备受关注。这篇Science文章吸引了我们的注意力。TB006是否有同样的问题呢?
![Science发文质疑:β淀粉样蛋白抗体,会导致阿尔茨海默病人大脑萎缩?](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
![Science发文质疑:β淀粉样蛋白抗体,会导致阿尔茨海默病人大脑萎缩?](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
![Science发文质疑:β淀粉样蛋白抗体,会导致阿尔茨海默病人大脑萎缩?](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
![Science发文质疑:β淀粉样蛋白抗体,会导致阿尔茨海默病人大脑萎缩?](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
参考资料:
封面图来源:pixabay
推荐阅读
![Science发文质疑:β淀粉样蛋白抗体,会导致阿尔茨海默病人大脑萎缩?](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
华盛顿病人 | 一个新疗法拯救阿尔兹海默病患者的神奇故事!
![Science发文质疑:β淀粉样蛋白抗体,会导致阿尔茨海默病人大脑萎缩?](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
辉瑞启示录:20年海外并购史带给国内Biotech到Big pharma的新思考
![Science发文质疑:β淀粉样蛋白抗体,会导致阿尔茨海默病人大脑萎缩?](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
4轮临床试验结果全矛盾,这减肥药,把积极结果做毁了……
![Science发文质疑:β淀粉样蛋白抗体,会导致阿尔茨海默病人大脑萎缩?](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
本篇文章来源于微信公众号: 药时代
发布者:haitao.zhao,转载请首先联系contact@drugtimes.cn获得授权